Fundsmith
CPRX · Medicine & biotech

Catalyst Pharmaceuticals

Sells Firdapse and other medicines for rare nerve and muscle diseases.
Sold all
Fundsmith sold all 844,887 of its Catalyst Pharmaceuticals shares between April and June. On March 31, 2026, they were worth about $21 million.
Mar 31
844,887
Jun 30
None

The numbers

Shares they used to own
844,887
Shares now
0
Value on Mar 31, 2026
$20,919,402
about $21 million
Kind
Shares
More about Catalyst Pharmaceuticals
The value uses the price on Mar 31, 2026. They may have sold at a different price.
See the original filing on SEC.gov
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works